The prevention of Tardive Dyskinesia with high dosage vitamins

[문형철]

마라토너 이봉주가 앓는 병으로 잘 알려진 근긴장이상증.

나을 수 있다는 이야긴데...

출처 : https://health.chosun.com/site/data/html_dir/2021/09/29/2021092902081.html

이봉주가 앓는 병 '근육긴장이상증'… 초기 증상은?

The prevention of Tardive Dyskinesia with high dosage vitamins: A study of 58,000 patients.

Export EXPORT Add To My ListEmailPrintShare

Journal ArticleDatabase: APA PsycInfo

---

---

Hawkins, David R.Citation

Hawkins, D. R. (1986). The prevention of Tardive Dyskinesia with high dosage vitamins: A study of 58,000 patients. Journal of Orthomolecular Medicine, 1(1), 24–26.

---

Abstract

Conducted a study in which 80 physicians, who prescribed megavitamins along with neuroleptic medicine, reported on the number of cases they had treated in this manner and the incidence of overt tardive dyskinesia (TD) among these Ss. Results indicate that 69 physicians treated a total of 41,972 Ss without a single case of TD; 11 physicians treated 16,070 Ss and reported collectively 26 TD cases. Findings suggest that the prescribing of high dosage vitamins B3, C, and B6, along with neuroleptic drugs, provides almost 100% protection against TD. (PsycINFO Database Record (c) 2016 APA, all rights reserved)

A Preventive Measure for Tardive Dyskinesia

Charles Tkacz, M.D.1 and David R. Hawkins, M.D.2

This paper is concerned ultimately with the presentation of a safe, effective and simple preventive measure for tardive dyskinesia (TD), a disease completely unknown to us during our years of early training in the 1950's, but one which seems now to be increasing in preval‎ence and severity before our eyes. Each month brings more journals with more reports concerning TD: two major articles in successive months this summer in the American Journal of Psychiatry; a major article in the summer issue of the Journal of the American Academy of Child Psychiatry, and so on. As seems to be the case so often with "new" diseases or with iatrogenic diseases, the articles read like detective stories: "The answers are here, Doctor, in front of you: but exactly where?" These are good papers, and like all good papers, they frequently admit to the unknown, sometimes contradict each other, but always show a desperate concern with trying to unravel the mystery that is TD. Two themes run through the history of ' Associate Medical Director North Nassau Mental Health Center 2 Medical Director North Nassau Mental Health Center medicine and psychiatry: the theme of iatrogenic illness, together with the theme of more or less accidental therapeutic discoveries. Sometimes the two intertwine. The findings we present here toward a preventive for TD were unanticipated, fortuitous, almost unscientific and anecdotal, yet they point the way toward a safe and effective preventive for this puzzling disease. There is almost universal agreement that TD is a movement disorder, associated somehow with long-term use of antipsychotic or neuroleptic medications. "Tardive" means of late onset; "dyskinesia" means abnormal movement. It is considered an extrapyramidal disorder yet distinct and, in fact, opposite from other extrapyramidal disorders such as pseudoparkinsonism. Early descriptions of the disorder now called TD were concerned with face and mouth movements to the point where clumsy terms like "lingual-facial-buccal dyskinesias", or "orofacial dyskinesias", or "buc-co-lingualmasticatory dyskinesias" were used. These seem all to have given way to the term TD which the 1975 American Psychiatric Association Glossary defined as "untoward effect, appearing after long term use of antipsychotic drugs with muscle involvement about the face, neck and trunk, lead-

Microsoft Word - 1981-v10n02-p119.doc (psu.edu)

[문형철]

https://www.psychiatrist.com/pcc/effects/metabolic-disorder/vitamin-d-deficiency-among-psychiatric-inpatients/